This category needs an editor. We encourage you to help if you are qualified.
Volunteer, or read more about what this involves.
Related categories
Subcategories:
318 found
Search inside:
(import / add options)   Sort by:
1 — 50 / 318
Material to categorize
  1. Mahesh Ananth & Mike Scheessele (2012). Exempting All Minimal-Risk Research From IRB Review: Pruning or Poisoning the Regulatory Tree? Irb 34 (2):9-14.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  2. Jonny Anomaly (2012). Is Obesity a Public Health Problem? Public Health Ethics 5 (3):216-221.
    It is often claimed that there is an obesity epidemic in affluent countries, and that obesity is one of the most serious public health threats in the developed world. I will argue that obesity is not an 'epidemic' in any useful sense of the word, and that classifying it as a public health problem requires us to make fairly controversial moral and empirical assumptions. While evidence suggests that the prevalence of obesity is on the rise, and that obesity can lead (...)
    Remove from this list | Direct download (10 more)  
     
    My bibliography  
     
    Export citation  
  3. Piers Benn (1992). AIDS and Sexual Morality. Philosophy Now 4:5-8.
  4. Nick Bostrom & Rebecca Roache (2007). Ethical Issues in Human Enhancement. In J. Ryberg, T. Petersen & C. Wolf (eds.), New Waves in Applied Ethics. Palgrave Macmillan. 120--152.
    Human enhancement has emerged in recent years as a blossoming topic in applied ethics. With continuing advances in science and technology, people are beginning to realize that some of the basic parameters of the human condition might be changed in the future. One important way in which the human condition could be changed is through the enhancement of basic human capacities. If this becomes feasible within the lifespan of many people alive today, then it is important now to consider the (...)
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  5. Michael C. Brannigan (2012). Cultural Fault Lines in Healthcare: Reflections on Cultural Competency. Lexington Books.
    Machine generated contents note: Introduction -- Chapter One: When Worldviews Collide -- Chapter Two: From Fault Lines to Cultural Competency -- Chapter Three: Cultural Discourse and Its Hurdles -- Chapter Four: On the Path to Presence -- Chapter Five: Cultivating Presence When There Is Distrust.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  6. Inmaculada de Melo-Martín & Kristen Intemann (2011). Feminist Resources for Biomedical Research: Lessons From the HPV Vaccines. Hypatia 26 (1):79-101.
    Several feminist philosophers of science have argued that social and political values are compatible with, and may even enhance, scientific objectivity. A variety of normative recommendations have emerged regarding how to identify, manage, and critically evaluate social values in science. In particular, several feminist theorists have argued that scientific communities ought to: 1) include researchers with diverse experiences, interests, and values, with equal opportunity and authority to scrutinize research; 2) investigate or “study up” scientific phenomena from the perspectives, interests, and (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  7. Andreas Dorschel (1994). Über moralische Bemühungen um Leben. Zeitschrift Für Didaktik der Philosophie Und Ethik 16 (4).
  8. Danny Frederick, Why People Should Be Free to Sell Their Organs.
  9. Inmaculada de Melo-martín & Kristen Intemann (2011). Feminist Resources for Biomedical Research: Lessons From the HPV Vaccines. Hypatia 26 (1):79 - 101.
    Several feminist philosophers of science have argued that social and political values are compatible with, and may even enhance, scientific objectivity. A variety of normative recommendations have emerged regarding how to identify, manage, and critically evaluate social values in science. In particular, several feminist theorists have argued that scientific communities ought to: 1) include researchers with diverse experiences, interests, and values, with equal opportunity and authority to scrutinize research; 2) investigate or "study up" scientific phenomena from the perspectives, interests, and (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  10. R. N. MN (2007). Exploring the Use of Feminist Philosophy Within Nursing Research to Enhance Post-Positivist Methodologies in the Study of Cardiovascular Health. Nursing Philosophy 8 (4):278–290.
  11. Tina Rulli, Ezekiel Emanuel & David Wendler (2012). The Moral Duty to Buy Health Insurance. Journal of the American Medical Association 308 (2):137-138.
    The 2010 Patient Protection and Affordable Care Act was designed to increase health insurance coverage in the United States. Its most controversial feature is the requirement that US residents purchase health insurance. Opponents of the mandate argue that requiring people to contribute to the collective good is inconsistent with respect for individual liberty. Rather than appeal to the collective good, this Viewpoint argues for a duty to buy health insurance based on the moral duty individuals have to reduce certain burdens (...)
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  12. Cynthia Ryan (2004). “Am I Not a Woman?” The Rhetoric of Breast Cancer Stories in African American Women's Popular Periodicals. Journal of Medical Humanities 25 (2):129-150.
    Representations of breast cancer are examined in three popular women's periodicals targeting African American readers: Ebony, Essence, and Black Elegance. The researcher focuses specifically on representations that reflect certain ideas/ideals about the sharing and creating of information about the disease and related issues, such as health care and body image. Magazine selections are analyzed and critiqued according to the epistemological principles outlined by Patricia Hill Collins in Black Feminist Thought. The author calls for further research into how and why particular (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  13. Jesper Ryberg, Thomas S. Petersen & Clark Wolf (eds.) (2007). New Waves in Applied Ethics. Palgrave Macmillan.
    This volume contains work by the very best young scholars working in Applied Ethics, gathering a range of new perspectives and thoughts on highly relevant topics, such as the environment, animals, computers, freedom of speech, human enhancement, war and poverty. For researchers and students working in or around this fascinating area of the discipline, the volume will provide a unique snapshot of where the cutting-edge work in the field is currently engaged and where it's headed.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  14. Benjamin Sachs (2011). Going From Principles to Rules in Research Ethics. Bioethics 25 (1):9-20.
    In research ethics there is a canon regarding what ethical rules ought to be followed by investigators vis-à-vis their treatment of subjects and a canon regarding what fundamental ethical principles apply to the endeavor. What I aim to demonstrate here is that several of the rules find no support in the principles. This leaves anyone who would insist that we not abandon those rules in the difficult position of needing to establish that we are nevertheless justified in believing in the (...)
    Remove from this list | Direct download (7 more)  
     
    My bibliography  
     
    Export citation  
  15. Lance Wahlert & Autumn Fiester (2012). Gender Transports: Privileging the “Natural” in Gender Testing Debates for Intersex and Transgender Athletes. American Journal of Bioethics 12 (7):19 - 21.
    The American Journal of Bioethics, Volume 12, Issue 7, Page 19-21, July 2012.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  16. Claudia Wiesemann (2011). Is There a Right Not to Know One's Sex? The Ethics of 'Gender Verification' in Women's Sports Competitions. Journal of Medical Ethics 37 (4):216-220.
    The paper discusses the current medical practice of "gender verification" in sports from an ethical point of view. It takes the recent public discussion about 800-meter runner Caster Semenya as a starting point. At the World Championships in Athletics 2009 in Berlin, Germany, Semenya was challenged by competitors as being a so called "sex impostor". A medical examination to verify her sex ensued. The author analyses whether athletes like Semenya could claim a right not to know that is generally acknowledged (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
Biotechnology Ethics
  1. Ademola A. Adenle (2014). Stakeholders' Perceptions of GM Technology in West Africa: Assessing the Responses of Policymakers and Scientists in Ghana and Nigeria. [REVIEW] Journal of Agricultural and Environmental Ethics 27 (2):241-263.
    The perception of two key stakeholders such as policymakers and scientists on genetic modification (GM) technology was examined in Ghana and Nigeria using semi-structured interviews. A total sample of 20 policymakers (16 at ministries and 4 at parliament/cabinet) and 58 scientists (43 at research institutes and 15 at universities) participated at the interviews. This study revealed respondents perspectives on potential benefits and risks of GM technology, status and development of biosafety regulatory frameworks, role of science and technology innovation in agricultural (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  2. Emmanuel Agius (2013). Biotechnology and Human Dignity. Human Reproduction and Genetic Ethics 17 (2):155 - 184.
    The precise meaning of “human dignity” is increasingly being questioned in ethics and law. Is human dignity an adequate guide to policymaking in today’s biotechnological era? This article is an attempt to answer this thorny issue. The emergence of the concept of human dignity as a key point of reference for the regulation of modern science and technology in the European Union is evaluated. The main contribution of this article is to prove that in EU Directives and Recommendations, human dignity (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  3. Jaime Ahlberg & Harry Brighouse (2011). An Argument Against Cloning. Canadian Journal of Philosophy 40 (4):539-566.
    It is technically possible to clone a human being. The result of the procedure would be a human being in its own right. Given the current level of cloning technology concerning other animals there is every reason to believe that early human clones will have shorter-than-average life-spans, and will be unusually prone to disease. In addition, they would be unusually at risk of genetic defects, though they would still, probably, have lives worth living. But with experimentation and experience, seriously unequal (...)
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  4. Fritz Allhoff, Patrick Lin & Jesse Steinberg (2011). Ethics of Human Enhancement: An Executive Summary. [REVIEW] Science and Engineering Ethics 17 (2):201-212.
    Remove from this list | Direct download (9 more)  
     
    My bibliography  
     
    Export citation  
  5. Joseph S. Alper & Jon Beckwith (1998). Distinguishing Genetic From Nongenetic Medical Tests: Some Implications for Antidiscrimination Legislation. Science and Engineering Ethics 4 (2):141-150.
    Genetic discrimination is becoming an increasingly important problem in the United States. Information acquired from genetic tests has been used by insurance companies to reject applications for insurance policies and to refuse payment for the treatment of illnesses. Numerous states and the United States Congress have passed or are considering passage of laws that would forbid such use of genetic information by health insurance companies. Here we argue that much of this legislation is severely flawed because of the difficulty in (...)
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  6. Latifah Amin & Hasrizul Hashim (forthcoming). Factors Influencing Stakeholders Attitudes Toward Genetically Modified Aedes Mosquito. Science and Engineering Ethics:1-27.
    Dengue fever is a debilitating and infectious disease that could be life-threatening. It is caused by the dengue virus which affects millions of people in the tropical area. Currently, there is no cure for the disease as there is no vaccine available. Thus, prevention of the vector population using conventional methods is by far the main strategy but has been found ineffective. A genetically modified (GM) mosquito is among the favoured alternatives to curb dengue fever in Malaysia. Past studies have (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  7. Ian Angell (2008). As I See It: Enclosing Identity. [REVIEW] Identity in the Information Society 1 (1):23-37.
    This article claims that an ‘enclosure of the commons’ is underway, which reaches far beyond intellectual property, to a point where, through profiling, ‘identity’ has itself become enclosed property that can be owned by another. With a detour through the natures of both money and innovation, this paper looks at the imperative driving ‘intellectual property rights.’ By introducing the notion of biopiracy, it shows how ‘invasion of privacy’ is justified, and ends with “a world of rapacious, state-aided ‘privatization’” of enclosed (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  8. Jonny Anomaly (2012). Review of Allen Buchanan, Beyond Humanity? The Ethics of Biomedical Enhancement. [REVIEW] Bioethics 26 (7):391-392.
    Remove from this list | Direct download (9 more)  
     
    My bibliography  
     
    Export citation  
  9. Richard Arneson, Is Moral Theory Perplexed by New Genetic Technology?
    Richard J. Arneson From Choice to Chance: Genes and the Just Society1 intelligently addresses difficult issues at the intersection of medical ethics and the theory of justice. The authors, Dan Brock, Allen Buchanan, Norman Daniels, and Daniel Wikler, repeatedly emphasize their opinion that advances in genetic technology force upon us entirely new ethical questions which previous moral theories lack the resources to resolve.2 The claims that new scientific discoveries render previous moral theories obsolete should be regarded with suspicion. The reader’s (...)
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  10. Andrew Askland (2003). Patenting Genes. International Journal of Applied Philosophy 17 (2):267-275.
    Patents have been issued in the United States for genes and gene sequences since 1980. Patent protection has provided incentives to aggressively probe the genome of humans and non-humans alike in search of profitable applications. Yet it is not clear that patent protection should have been afforded to genes and gene sequences and it is increasingly clear that patent protection, as currently formulated, is not an appropriate means to realize the full benefits of genetic research. As we stand on the (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  11. Christoph Asmuth, Benedetta Bisol & Patrick Grüneberg (2010). Modelle und Grenzen der Leistungssteigerung im Sport: Enhancement, Doping, Therapie aus philosophischer Sicht. Leipziger Sportwissenschaftliche Beiträge 51 (2):8-43.
    Enhancement is a basic principle of modern sport. Their increase of achievement is usually attributed to the sportsmen’s natural assessment, their health, their training methods and their employment. In contrast, increase in output by pharmacological means is outlawed. The modern medical techniques created a whole range, by which sportsmen are supported. Consequently, sometimes difficult decisions with concrete medications develop. It is not always clearly to be differentiated whether something is a pharmacological interference, which serves the therapy or leads however to (...)
    Remove from this list |
    Translate to English
    | Direct download  
     
    My bibliography  
     
    Export citation  
  12. Robin Attfield (2012). Synthetic Biology, Deontology and Synthetic Bioethics. Ethics, Policy and Environment 15 (1):29 - 32.
    Paul Thompson argues that current synthetic biology amounts to synthetic genomics, comprising a ?platform? technology, and that Christopher Preston's deontological objections based on its supposed rejection of the historical process of evolution miscarry. This makes it surprising that Thompson's normative ethic consists in a deontological appeal to Kantian duties of imperfect obligation. Construed as obligations subject to choice, such constraints risk being excessively malleable where the ethical objections to deployment of this technology concern land rights and/or exploitation. Thompson's advocacy of (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  13. Wendy Baldwin (2002). Conflict of Interest and its Significance in Science and Medicine Warsaw, Poland, 5–6 April, 2002. Science and Engineering Ethics 8 (3):469-475.
    This article summarizes the April 5–6, 2002 conference on Conflict of Interest and Its Significance in Science and Medicine. Several themes are identified and addressed, including the globalization of science, the widespread presence of conflicts, the increased interest and involvement in conflict of interest by a number of organizations, the difference between academic research and research conducted by industry, and the tension between science and medicine. At the heart of the matter lies objectivity in research and the need for transparency (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  14. John Basl (2010). State Neutrality and the Ethics of Human Enhancement Technologies. AJOB 1 (2):41-48.
    Robust technological enhancement of core cognitive capacities is now a realistic possibility. From the perspective of neutralism, the view that justifications for public policy should be neutral between reasonable conceptions of the good, only members of a subset of the ethical concerns serve as legitimate justifications for public policy regarding robust technological enhancement. This paper provides a framework for the legitimate use of ethical concerns in justifying public policy decisions regarding these enhancement technologies by evaluating the ethical concerns that arise (...)
    Remove from this list |
    Translate to English
    |
     
    My bibliography  
     
    Export citation  
  15. Tom L. Beauchamp (1987). Medical Ethics in the Age of Technology. In Hans Mark & W. Lawson Taitte (eds.), Traditional Moral Values in the Age of Technology. Distributed by the University of Texas Press.
  16. Volkert Beekman & Frans W. A. Brom (2007). Ethical Tools to Support Systematic Public Deliberations About the Ethical Aspects of Agricultural Biotechnologies. Journal of Agricultural and Environmental Ethics 20 (1):3-12.
    This special issue of the Journal of Agricultural and Environmental Ethics presents so-called ethical tools that are developed to support systematic public deliberations about the ethical aspects of agricultural biotechnologies. This paper firstly clarifies the intended connotations of the term “ethical tools” and argues that such tools can support liberal democracies to cope with the issues that are raised by the application of genetic modification and other modern biotechnologies in agriculture and food production. The paper secondly characterizes the societal discussion (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  17. Frederick R. Bieber (2006). Turning Base Hits Into Earned Runs: Improving the Effectiveness of Forensic DNA Data Bank Programs. Journal of Law, Medicine Ethics 34 (2):222-233.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  18. Nick Bostrom (forthcoming). Smart Policy: Cognitive Enhancement and the Public Interest. In Julian Savulescu, Ruud ter Muelen & Guy Kahane (eds.), Enhancing Human Capabilities. Wiley-Blackwell.
    Cognitive enhancement may be defined as the amplification or extension of core capacities of the mind through improvement or augmentation of internal or external information processing systems. Cognition refers to the processes an organism uses to organize information. These include acquiring information (perception), selecting (attention), representing (understanding) and retaining (memory) information, and using it to guide behavior (reasoning and coordination of motor outputs). Interventions to improve cognitive function may be directed at any of these core faculties.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  19. Frans W. A. Brom (2000). The Good Life of Creatures with Dignity Some Comments on the Swiss Expert Opinion. Journal of Agricultural and Environmental Ethics 13 (1):53-63.
    The notion of Dignity of Creatures has been voted into the Swiss Federal Constitution by a plebiscite. Philipp Balzer, Klaus-Peter Rippe, and Peter Schaber have given an expert opinion for the Swiss government to clarify the notion of Dignity of Creatures. According to them, by voting this notion into the Swiss constitution, the Swiss have chosen for a limited biocentric approach towards biotechnology. In such an approach genetic engineering of non-human beings is only allowed insofar that their own good is (...)
    Remove from this list | Direct download (8 more)  
     
    My bibliography  
     
    Export citation  
  20. Jeffrey Burkhardt (2001). Agricultural Biotechnology and the Future Benefits Argument. Journal of Agricultural and Environmental Ethics 14 (2):135-145.
    In the face of criticisms about the current generationof agricultural biotechnology products, some proponents ofagricultural biotechnology offer a ``future benefitsargument''''(FBA), which is a utilitarian ethical argument thatattempts to justify continued R&D. This paper analyzes severallogical implications of the FBA. Among these are that acceptanceof the FBA implies (1) acceptance of a precautionary approach torisk, (2) the need for a more proportional and equitabledistribution of the benefits of agricultural biotechnology, andmost important, (3) the need to reorient and restructurebiotechnology R&D institutions (and (...)
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  21. Jeanne L. Burton & Brian W. McBride (1989). Recombinant Bovine Somatotropin (rbST): Is There a Limit for Biotechnology in Applied Animal Agriculture? Journal of Agricultural and Environmental Ethics 2 (2):129-159.
    The intent of this article is to outline, integrate, and interpret relevant scientific, economic, and social issues of rbST technology that have contributed to the acceptance dilemma for this product. The public is divided into social groups, each with its own set of criteria on which they base rbSTs acceptability. Criteria for the scientific community may best be described as physiological. However, for consumers, criteria may be more practical, or procedural, including human health, animal welfare, environmental concerns, and overproduction. Because (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  22. Martin Calkins (2002). How Casuistry and Virtue Ethics Might Break the Ideological Stalemate Troubling Agricultural Biotechnology. Business Ethics Quarterly 12 (3):305-330.
    Abstract: This article begins by showing how recent controversies over the widespread promotion of artificially gene-altered foods are rooted in opposing ethical and ideological worldviews. It then explains how these contrasting worldviews have led to a practical, ethical, and ideological standoff and, finally, suggests the combined use of casuistry and virtue ethics as a way for both sides to move ahead on this pressing issue.
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  23. Margaret A. Clark (1999). This Little Piggy Went to Market: The Xenotransplantation and Xenozoonose Debate. Journal of Law, Medicine and Ethics 27 (2):137-152.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  24. Benjamin M. Cole & Preeta M. Banerjee (2013). Morally Contentious Technology-Field Intersections: The Case of Biotechnology in the United States. [REVIEW] Journal of Business Ethics 115 (3):555-574.
    Technologies can be not only contentious—overthrowing existing ways of doing things—but also morally contentious—forcing deep reflection on personal values and societal norms. This article investigates that what may impede the acceptance of a technology and/or the development of the field that supports or exploits it, the lines between which often become blurred in the face of morally contentious content. Using a unique dataset with historically important timing—the United States Biotechnology Study fielded just 9 months after the public announcement of the (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  25. Anthony Mark Cutter & Bert Gordijn (2007). Questions of Human Enhancement: An Editorial. Studies in Ethics, Law, and Technology 1 (1).
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  26. Rafael Dal-Re, Xavier Carné & Diego Gracia (eds.) (2013). Luces y sombras en la investigación clínica. Triacastela, Fundació Víctor Grífols I Lucas.
    La investigación clínica, entendida como la búsqueda de soluciones para los problemas que acechan a la salud es, por su objetivo, una de las actividades de mayor trascendencia para el ser humano. Esta obra colectiva, como su propio título indica, explora no solo lo mucho que de positivo (las luces) tiene la investigación clínica, cómo se realiza, qué problemas encuentra y qué soluciones se plantean, sino también algunos aspectos negativos (las sombras) que la comunidad científica ha sido, hasta la fecha, (...)
    Remove from this list |
    Translate to English
    | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  27. Aubrey D. N. J. de Grey (2007). Life Span Extension Research and Public Debate: Societal Considerations. Studies in Ethics, Law, and Technology 1 (1).
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  28. Adalberto de Hoyos, Rodrigo Nava-Diosdado, Jorge Mendez, Sergio Ricco, Ana Serrano, Carmen Flores Cisneros, Carlos Macías-Ojeda, Héctor Cisneros, David Bialostozky, Nelly Altamirano-Bustamante & Myriam Altamirano-Bustamante (2013). Cardiovascular Medicine at Face Value: A Qualitative Pilot Study on Clinical Axiology. Philosophy, Ethics, and Humanities in Medicine 8 (1):3.
    Cardiology is characterized by its state-of-the-art biomedical technology and the predominance of Evidence-Based Medicine. This predominance makes it difficult for healthcare professionals to deal with the ethical dilemmas that emerge in this subspecialty. This paper is a first endeavor to empirically investigate the axiological foundations of the healthcare professionals in a cardiology hospital. Our pilot study selected, as the target population, cardiology personnel not only because of their difficult ethical deliberations but also because of the stringent conditions in which they (...)
    Remove from this list | Direct download (11 more)  
     
    My bibliography  
     
    Export citation  
  29. Annette Dufner (2013). Potentiality Arguments and the Definition of “Human Organism”. American Journal of Bioethics 13 (1):33-34.
    Bettina Schöne-Seifert and Marco Stier present a host of detailed and intriguing arguments to the effect that potentiality arguments have to be viewed as outdated due to developments in stem cell research, in particular the possibility of re-setting the development potential of differentiated cells, such as skin cells. However, their argument leaves them without an explanation of the intuitive difference between skin cells and human beings, which seems to be based on the assumption that a skin cell is merely part (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  30. Margaret L. Eaton (2004). Ethics and the Business of Bioscience. Stanford Business Books.
    Businesses that produce bioscience products—gene tests and therapies, pharmaceuticals, vaccines, and medical devices—are regularly confronted with ethical issues concerning these technologies. Conflicts exist between those who support advancements in bioscience and those who fear the consequences of unfettered scientific license. As the debate surrounding bioscience grows, it will be increasingly important for business managers to consider the larger consequences of their work. This groundbreaking book follows industry research, development, and marketing of medical and bioscience products across a variety of fields, (...)
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  31. Ron Epstein, Buddhism and Biotechnology.
    The topic of this panel is "Biotechnology: Boon or Bane for Spiritual Development." It has very often been said that we are on the threshold of the biotech century, and I am sure that all of you are very clearly aware that genetic engineering is going to totally reshape life on this planet in many ways: economically, politically, scientifically--particularly in terms of medicine, and also environmentally. Most important for all of us is what the relationship of this incredible technology will (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  32. N. G. Evans (2013). Great Expectations—Ethics, Avian Flu and the Value of Progress. Journal of Medical Ethics 39 (4):209-213.
    A recent controversy over the US National Science Advisory Board for Biosecurity's recommendation to censor two publications on genetically modified H5N1 avian influenza has generated concern over the threat to scientific freedom such censorship presents. In this paper, I argue that in the case of these studies, appeals to scientific freedom are not sufficient to motivate a rejection of censorship. I then use this conclusion to draw broader concerns about the ethics of dual-use research.
    Remove from this list | Direct download (7 more)  
     
    My bibliography  
     
    Export citation  
  33. Obidimma C. Ezezika, Jennifer Deadman & Abdallah S. Daar (2013). She Came, She Saw, She Sowed: Re-Negotiating Gender-Responsive Priorities for Effective Development of Agricultural Biotechnology in Sub-Saharan Africa. [REVIEW] Journal of Agricultural and Environmental Ethics 26 (2):461-471.
    In this paper, we argue for the importance of incorporating a gendered perspective for the effective development of sustainable agricultural biotechnology systems in sub-Saharan Africa. Priority setting for agricultural policy and project development requires attention to gender issues specific to the demands of agricultural biotechnology. This is essential for successfully addressing food security and poverty reduction in sub-Saharan Africa (SSA). There has been a great deal of debate and literature on the implications of gender in agricultural development and policy. However, (...)
    Remove from this list | Direct download (7 more)  
     
    My bibliography  
     
    Export citation  
  34. Ruth Faden & Madison Powers (2013). Biotechnology, Justice and Health. Journal of Practical Ethics 1 (1):49-61.
    New biotechnologies have the potential to both dramatically improve human well-being and dramatically widen inequalities in well-being. This paper addresses a question that lies squarely on the fault line of these two claims: When as a matter of justice are societies obligated to include a new biotechnology in a national healthcare system? This question is approached from the standpoint of a twin aim theory of justice, in which social structures, including nation-states, have double-barreled theoretical objectives with regard to human well-being. (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
1 — 50 / 318